Axcynsis Therapeutics

About:

Tetris Therapeutics is a platform-based biotechnology company

Top Investors: Trinity Innovation Bioventure Singapore

Description:

Tetris Therapeutics is a platform-based biotechnology company focusing on the development of antibody drug conjugate (ADC) therapies to revolutionise cancer treatments. Leveraging on proprietary technologies, we are developing a robust pipeline of ADC candidates with the potential to address unmet medical needs for new treatment options.

Total Funding Amount:

$15M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2021-01-01

Contact Email:

contactus(AT)tetris.com.sg

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-05-04

IPO Status:

Private

Industries: